The Makers of Phony Negroni Are on Track to Sell 2 Million Bottles This Year. How the Nonalcoholic Spirits Industry Is Coming of Age
With a flood of competitors and conglomerates eyeing the market, brands are working to create a buzz in the new world of ...
WebMD3d
FDA Approves New Targeted Treatment for Biliary Tract Cancer
The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...
Campbell’s shareholders approve the company’s new, soupless name
Campbell Soup Co. announced its intention to change its name just over two months ago, saying it wanted to instead be known as the (slightly shorter) Campbell’s Co. Shareholders overwhelmingly ...
The FDA Can’t Decide Whether Zepbound Is in Shortage. It’s Good News for Hims & Hers Stock.
The Food and Drug Administration told a federal judge Thursday that it needs more time to reconsider whether Eli Lilly’s ...
BioWorld4d
Celltrion wins Korea approvals of Prolia, Xgeva biosimilars
The Ministry of Food and Drug Safety (MFDS) approved South Korea’s first denosumab (Prolia/Xgeva) biosimilars, developed by Celltrion Inc. under the brand names of Stoboclo/Osenvelt (CT-P41) for ...
FiercePharma5d
Jazz's HER2 bispecific snags FDA nod, teeing up showdown with AZ and Daiichi's Enhertu
The new drug, Jazz Pharmaceuticals’ zanidatamab, has won an FDA accelerated approval for adults with previously treated ...